Articles tagged "Outcome"

2019 American Transplant Congress
Impact of MELD-Na Course (Delta MELD-Na) on Outcome after Liver Transplantation
G. Silberhumer¹, G. Gyoeri¹, L. Unger², G. Harpain¹
¹Transplant Surgery, Medical University Vienna, Vienna, Austria, ²Institute for Mathematics and Bioscience, Medical University Vienna, Vienna, Austria
*Purpose: Currently, MELD Score listing is state of the art for liver transplant recipients. Our department could show by our own institutional data and confirmed…
2019 American Transplant Congress
Initial Single-Center Results from the Pilot Transplant Quality Improvement Project in Liver Transplant
A. Zarinsefat, S. M. Syed, R. Hirose
UC San Francisco, San Francisco, CA
*Purpose: The National Surgical Quality Improvement Program (NSQIP) has been an effective measure in improving the quality of surgical care, while also providing data to…
2019 American Transplant Congress
Multicenter Experience Evaluating Outcomes of HCV-Seropositive Donors to HCV-Seronegative Recipients Liver Transplantation
K. Wijarnpreecha¹, B. Aqel², S. Pungpapong¹, C. Taner³, K. Reddy⁴, M. Leise⁵, R. Dickson²
¹Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, ²Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, ³Transplant, Mayo Clinic, Jacksonville, FL, ⁴Transplant and Hepatobiliary Surgery, Mayo Clinic, Scottsdale, AZ, ⁵Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN
*Purpose: Grafts from hepatitis C virus (HCV)-seropositive donors can now be considered for liver transplant (LT) due to the advent of direct-acting antiviral agents (DAA).…
2019 American Transplant Congress
Pathologic Vascular Invasion Correlates with Worse Outcome in Hepatoblastoma Patients Treated with Liver Transplantation – A Hepatoblastoma Transplant Consortium Study
T. H. Malik¹, H. Zhu², T. Ha³, S. Commander⁴, C. Trautz⁵, R. Sindhi⁵, S. Kim⁶, K. Vakili⁶, N. Vachharajani⁷, W. Chapman⁷, A. Griesemer⁸, M. Martinez⁸, J. A. Goss⁹, S. Vasudevan¹⁰
¹Baylor College of Medicine, Houston, TX, ²Texas Children's Hospital, Houston, TX, ³Department of Surgery, Baylor College of Medicine, Houston, TX, ⁴Department of Surgery, Duke University School of Medicine, Durham, NC, ⁵Department of Surgery, University of Pittsburgh, Pittsburgh, PA, ⁶Department of Surgery, Boston Children's Hospital, Boston, MA, ⁷Department of Surgery, Washington University School of Medicine in St. Louis, St. Louis, MO, ⁸Department of Surgery, NewYork-Presbyterian Morgan Stanley Children's Hospital, New York, NY, ⁹Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX, ¹⁰Department of Pediatric Surgery, Texas Children's Hospital, Houston, TX
*Purpose: Orthotopic liver transplant (OLTx) is the most common method to treat unresectable hepatoblastoma (HB) in children. There is limited data focusing on the outcomes…
2019 American Transplant Congress
Center Variability in Organ Offer Acceptance and Waitlist Mortality in Lung Transplantation
A. Y. Choi¹, M. S. Mulvihill², J. Weber³, H. Lee³, M. Cox², B. Yerokun², M. Kuchibhatla³, J. A. Klapper², M. G. Hartwig²
¹Duke University School of Medicine, Durham, NC, ²Department of Surgery, Duke University Medical Center, Durham, NC, ³Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC
*Purpose: Lung transplantation (LTx) offers a survival benefit for patients with end-stage lung disease. When suitable donors are identified, centers must accept or decline the…
2019 American Transplant Congress
Simultaneous Pancreas and Kidney Transplant Outcomes after Induction Therapy with Thymoglobulin Compared with Alemtuzumab
B. Masters¹, F. Bartlett², C. Drachenberg³, S. Bartlett³, R. Barth³, J. Scalea³, A. Haririan³
¹University of Maryland Medical Center, Baltimore, MD, ²Barnes-Jewish Hospital, St. Louis, MO, ³University of Maryland, School of Medicine, Baltimore, MD
*Purpose: The purpose of this study is to compare the outcomes of simultaneous pancreas and kidney transplant (SPK) recipients after two T-cell depleting induction agents:…
2019 American Transplant Congress
Can Cardiac Risk Predictor Models Be Trusted in Kidney Transplant Recipients?
K. L. Hoffman¹, R. R. Alloway¹, A. Shields², E. Woodle², A. Govil¹
¹Nephrology & Transplant Medicine, University of Cincinnati, Cincinnati, OH, ²Transplant Surgery, University of Cincinnati, Cincinnati, OH
*Purpose: Kidney transplant recipients (KTR) bear a higher risk of developing cardiovascular disease due to comorbid conditions. Non-invasive cardiovascular risk stratification tools have not been…
2019 American Transplant Congress
The Combination of 3-Month Estimated Glomerular Filtration Rate and Proteinuria is a Valuable Tool for Evaluating Long-Term Kidney Graft Survival
C. Mottola¹, N. Girerd², K. Duarte³, A. Aarnink⁴, M. Kessler⁵, L. Frimat⁶, S. Girerd⁶
¹Nephrology and Kidney Transplant Unit, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France, ²Clinical Investigation Center 1433, INSERM U1116, INI-CRCT, F-CRIN, Lorraine University, Vandoeuvre-lès-Nancy, France, ³Clinical Investigation Center 1433, INSERM 1116, INI-CRCT, F-CRIN, Lorraine Univeristy, Vandoeuvre-lès-Nancy, France, ⁴Laboratoire d’Histocompatibilité, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France, ⁵Nephrology and kidney transplant unit, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France, ⁶Nephrology and kidney transplant unit, INI-CRCT, F-CRIN, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France
*Purpose: Estimated glomerular filtration rate (eGFR) measured at 1 year is the usual outcome used to predict the long-term graft survival in the field of…
2019 American Transplant Congress
Transfer of Healthy Mitochondria in Established Ischemic Injury Reduces Progression to Interstitial Fibrosis and Tubular Atrophy
A. Bajwa¹, V. Bontha¹, D. Maluf¹, J. Eason², V. Mas³
¹UTHSC, Memphis, TN, ²Director of Transplant Institute, Memphis, TN, ³Director of Transplant Research Institute, Memphis, TN
*Purpose: Ischemia induces altered bioenergetics with increased mitochondrial swelling and reactive oxygen species (ROS) and ultimately degradation of cellular function. Therapeutic interventions that target to…
2019 American Transplant Congress
Induction Type Does Not Influence Kidney Graft or Patient Survival in Recipients with a Previous Heart Transplant in the United States
S. M. Riad¹, A. Tamas¹, S. Jackson², C. Martin¹
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, Fairview Health Services, Minneapolis, MN
*Purpose: Induction regimens for kidney transplant (KT) in heart recipients vary widely among transplant centers. We sought to examine the impact of kidney induction type…